- Home
- IKT vs CRNT Comparison
IKT vs CRNT Comparison
Compare IKT & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IKT | CRNT |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.1M | 206.7M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IKT | CRNT |
|---|---|---|
| Price | $1.85 | $2.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $5.50 | $4.00 |
| AVG Volume (30 Days) | ★ 2.2M | 344.4K |
| Earning Date | 11-14-2025 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.32 |
| Revenue Next Year | N/A | $6.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $1.82 |
| 52 Week High | $2.46 | $2.84 |
Technical Indicators
Market Signals| Indicator | IKT | CRNT |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 47.28 |
| Support Level | $1.45 | $2.23 |
| Resistance Level | $2.10 | $2.40 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 24.19 | 38.71 |
Price Performance
Historical ComparisonAbout IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.